High Intensity Focused Ultrasound (HIFU) is Cutting Edge, Intensely focused Ultrasound, therapy for prostate cancer that destroys tissue with rapid heat elevation, essentially “cooking” it. Ultrasound energy, or sound waves, is focused at a specific location, raising the temperature to almost 90 degrees Celsius in seconds. Tissue outside the focal point is unharmed, allowing the patient to have a non-surgical, limited blood loss, quick recovery, outpatient, radiation free treatment.
Although studies cannot show long range (20-30 year outcomes) they do indicate this treatment is comparable to standard treatments with the added benefit of low risk of impotence or incontinence. The FDA has not approved the Sonablate® 500 for use within the US, but it is being studied for clinical trials here and has been approved in Canada, Argentina, Dominican Republic, the Bahamas, and Mexico. Dr. Giesler and Dr. Chopp are offering an informational seminar about this new technology.